Lu S, Zhang Y, Zhang G, Zhou J, et al. Efficacy and safety of befotertinib (D-0316) in patients with EGFR T790M mutated non-small cell lung cancer that had progressed after prior EGFR TKI therapy: A phase 2, multicenter, single-arm, open-label study. J Thorac Oncol 2022 Jun 17. pii: S1556-0864(22)00297.
PMID: 35724798